EUVIMEDEUVIMED entdecken
Crossref

Impact of COVID-19 vaccination on clinical outcomes in kidney transplant patients

Ana Flávia Vieira Ferreira de Assis, Letícia de Oliveira Santos, Mariana Almeida Botelho, Evaldo Nascimento, Raquel A Fabreti-Oliveira

Transplant Immunology · 2024

DOI: 10.1016/j.trim.2024.102019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Immunology, 2024. Verfasst von Ana Flávia Vieira Ferreira de Assis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medical Sciences, Belo Horizonte, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Kidney Transplantation, COVID-19, COVID-19 Vaccines, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The global health crisis caused by the COVID-19 pandemic has resulted in severe mortality and morbidity. Immunosuppressed patients, such as kidney transplant recipients, are particularly susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. OBJECTIVE: The aim of this cohort study was to evaluate the impact of COVID-19 vaccination on clinical outcomes in patients with kidney transplants. MATERIALS AND METHODS: In this retrospective study, 254 patients with kidney transplants were vaccinated against SARS-CoV-2 and a fraction of these contracted COVID-19. The diagnosis of COVID-19 was carried out by reverse transcriptase-polymerase chain reaction testing, and the patients received treatment involving immunosuppressive and COVID-19-specific protocols. RESULTS: SARS-CoV-2 infection was diagnosed in 38 (14.96%) patients before the COVID-19 vaccine was administered. After vaccination, an additional 29 (11.42%) patients were diagnosed with COVID-19. Risk factors for hospitalization included age, body mass index (BMI), comorbidities, and time elapsed since renal transplantation (p = 0.025, 0.038, 0.012, and 0.046, respectively). COVID-19 vaccination resulted in a significant decrease in the rate of hospital-acquired SARS-CoV-2 infection from 63.16% to 34.48% (p = 0.020). The proportion of patients from this cohort placed in intensive care units decreased from 23.68% to zero. Allograft rejections exhibited a decreasing trend from 13.16% to 6.90% (p = 0.690). This patient cohort displayed 15.79% mortality prior to COVID-19 vaccination that was reduced to nil after immunization. CONCLUSION: COVID-19 vaccination significantly reduced COVID-19 severity and mortality in this cohort of patients with kidney transplants. The risk factors for hospitalization were determined to be age, BMI, comorbidities, and time since renal transplantation. COVID-19 vaccination resulted in a clinical outcome of reduced hospitalization and a decrease in clinical complications. The COVID-19 vaccination-derived adverse effects in this cohort were found to be comparable to those in the immunocompetent population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationCOVID-19COVID-19 VaccinesSARS-CoV-2VaccinationHumansMaleFemaleMiddle AgedRetrospective StudiesAdultAgedRisk FactorsImmunocompromised HostHospitalizationTreatment Outcome

Stichwörter der Autor:innen

Adverse effectsCOVID-19 vaccinesImmunosuppression therapyKidney transplantation outcomeSevere acute respiratory syndrome coronavirus 2

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Faculty of Medical Sciences, Belo Horizonte, Minas Gerais, Brazil.
  • IMUNOLAB - Laboratory of Histocompatibility, Belo Horizonte, Minas Gerais, Brazil; Faculty of Health of the Hospital Santa Casa, Belo Horizonte, Minas Gerais, Brazil. Electronic address: evaldo@imunolab.com.br.
  • Faculty of Medical Sciences, Belo Horizonte, Minas Gerais, Brazil; IMUNOLAB - Laboratory of Histocompatibility, Belo Horizonte, Minas Gerais, Brazil. Electronic address: raquel.fabreti@cienciasmedicasmg.edu.br.

Zitieren

APA

de Assis, A. F. V. F., de Oliveira Santos, L., Botelho, M. A., Nascimento, E., & Fabreti-Oliveira, R. A. (2024). Impact of COVID-19 vaccination on clinical outcomes in kidney transplant patients. Transplant Immunology. https://doi.org/10.1016/j.trim.2024.102019

Vancouver

de Assis AFVF, de Oliveira Santos L, Botelho MA, Nascimento E, Fabreti-Oliveira RA. Impact of COVID-19 vaccination on clinical outcomes in kidney transplant patients. Transplant Immunology. 2024. doi:10.1016/j.trim.2024.102019

BibTeX
@article{deAssis2024,
  author = {de Assis, Ana Flávia Vieira Ferreira and de Oliveira Santos, Letícia and Botelho, Mariana Almeida and Nascimento, Evaldo and Fabreti-Oliveira, Raquel A},
  title = {Impact of COVID-19 vaccination on clinical outcomes in kidney transplant patients},
  journal = {Transplant Immunology},
  year = {2024},
  doi = {10.1016/j.trim.2024.102019}
}
Kostenlos starten →